Loading...
XNASSMLR
Market cap547mUSD
Jan 06, Last price  
58.06USD
1D
8.13%
1Q
136.25%
Jan 2017
3,971.72%
IPO
749.50%
Name

Semler Scientific Inc

Chart & Performance

D1W1MN
XNAS:SMLR chart
P/E
26.14
P/S
7.89
EPS
2.22
Div Yield, %
0.00%
Shrs. gr., 5y
0.49%
Rev. gr., 5y
25.98%
Revenues
68m
+20.28%
316,0001,199,0002,274,0003,635,0007,001,0007,434,00012,452,00021,491,00032,767,00038,603,00053,027,00056,686,00068,184,000
Net income
21m
+43.69%
-1,876,000-2,741,000-2,233,000-4,515,000-8,501,000-2,554,000-1,510,0005,014,00015,084,00014,007,00017,222,00014,325,00020,583,000
CFO
21m
+22.14%
-1,275,000-1,821,000-1,192,000-3,822,000-4,135,000-1,804,000621,0004,697,00012,728,00015,417,00016,056,00017,463,00021,330,000
Earnings
Mar 03, 2025

Profile

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
URL
https://www.semlerscientific.com/
IPO date
Feb 27, 2014
Employees
127
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
68,184
20.28%
56,686
6.90%
Cost of revenue
45,194
39,483
Unusual Expense (Income)
NOPBT
22,990
17,203
NOPBT Margin
33.72%
30.35%
Operating Taxes
3,517
3,367
Tax Rate
15.30%
19.57%
NOPAT
19,473
13,836
Net income
20,583
43.69%
14,325
-16.82%
Dividends
Dividend yield
Proceeds from repurchase of equity
(1,949)
(4,823)
BB yield
0.56%
1.83%
Debt
Debt current
90
85
Long-term debt
230
405
Deferred revenue
Other long-term liabilities
(2,298)
Net debt
(62,764)
(48,097)
Cash flow
Cash from operating activities
21,330
17,463
CAPEX
(828)
(2,160)
Cash from investing activities
18,396
(26,835)
Cash from financing activities
(5,408)
(4,937)
FCF
14,988
20,310
Balance
Cash
57,200
43,087
Long term investments
5,884
5,500
Excess cash
59,675
45,753
Stockholders' equity
59,810
39,227
Invested Capital
12,280
12,473
ROIC
157.34%
85.71%
ROCE
31.95%
31.86%
EV
Common stock shares outstanding
7,819
8,000
Price
44.29
34.21%
33.00
-63.99%
Market cap
346,311
31.18%
263,992
-64.61%
EV
283,547
215,895
EBITDA
23,589
17,792
EV/EBITDA
12.02
12.13
Interest
489
Interest/NOPBT
2.84%